ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Viridian Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Viridian Therapeutics, INC. (Viridian Therapeutics, INC. 401(k) Plan · EIN 47-1187261 · PN 001): $11.64M net assets, 139 active participants, and $14.12 per $10,000 (14.12 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorViridian Therapeutics, INC.
Filing IdentifierViridian Therapeutics, INC. 401(k) Plan · EIN 47-1187261 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$11.64M
Active Participants139
Direct Admin Fee Rate$14.12 per $10,000 (14.12 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderVanguard
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI